"The acquisition of Biomatters is an exciting opportunity to better serve our customers and the scientific community," said Thomas Swalla, CEO of GraphPad. "There is a critical need for scientists and researchers to leverage technology in a way that enhances-not impedes-innovation. The acquisition creates a life sciences software platform with technology and data analysis at the core of scientific research around the world. SAN DIEGO, Ap/PRNewswire/ - GraphPad, a leading provider of data analysis and visualization software for the life sciences industry, announced today that it will acquire Biomatters, a leading provider of Geneious DNA data analysis solutions.
0 kommentar(er)
